"I-Excidzhad" (deferaziroks): ama-analogues, intengo. Lapho ukuthenga i-Adwizard

"I-Excidzhad" ibhekisela eqenjini lezidakamizwa eziyinkimbinkimbi futhi isetshenziselwa ekwelapheni ukuxilongwa kwe-post-transfusion engenamaphesenti angaphezu kwesikhashana kanye nokweqa okungapheli kokungeniswa igazi ezigulini ezine-thalassemia, ngenxa yekhono eliphezulu lokubopha insimbi nokulihoxisa.

Isidakamizwa asikona kuphela abantu abadala, kodwa futhi sisetshenziselwa iziguli ezincane ezingaphezu kweminyaka emibili.

"I-Excidzhad" yisidakamizwa saseSwitzerland. Itholakala kumathebulethi. Kuye ngomthamo wesithako esisebenzayo esikhulu "kwi-Eksidzhad" intengo isethwe kuma-ruble angu-60 000-90 000 ngokupakisha. Noma kunjalo, ungathenga umuthi futhi ushibhile.

Iyini isidakamizwa esijwayelekile

Naphezu kokuthi inani lokuqala "i-Exidzhad" liphakeme ngokwanele, kunomuthi ofanayo wezidakamizwa nokusebenza kahle, onokuphindwa izikhathi ezimbalwa. Lona okubizwa ngokuthi okuvamile. Ikhiqizwa yinkampani yaseNdiya enemvume yonke yalolu hlobo lomsebenzi.

I-formula yemithi ye-Pharmacological generic ayifani nalokho esetshenziselwa umuthi wokuqala, ngakho-ke, nokusebenza kwezidakamizwa kuyafana. Kodwa kungani umuthi waseNdiya ubiza kancane? Into ewukuthi umkhiqizi usebenzisa ifomula eseyithuthukile kakade, ukuhlolwa kwemitholampilo sekuvele kwenziwa, futhi akudingeki ukuthi usebenzise imali ekukhangiseni. Ngakho, izindleko zokukhiqiza zinciphile kakhulu. Yilokho okwenza kube lula ukukhiqiza izidakamizwa ezibalulekile kubantu abaningi ngentengo engabizi.

Lapho ukuthenga "Eksidzhad" eshibhile

Uma unesithakazelo ekuthengeni isidakamizwa esibucayi esicatshangelwe, qaphela isayithi WWW.ONKO24.COM . Lapha uzosizwa ukuthi uhlele umkhiqizo wokwelapha ovela eNdiya kumkhiqizi.

Ungathenga i- "Exidzhad", enezincwadi eziqinisekisa isidingo sokusebenzisa le mithi ekwelapheni. Ngakho-ke, lungiselela isigqebhezana esivela kudokotela kusengaphambili.

"Exidzhad": imiyalelo yokusetshenziswa

Uma kunesidingo esingenasiphelo sokumpontshelwa ngemuva kwensimbi, ama-dose abalwa futhi ahlanganiswe ukuze ahambisane nomthamo wethebhulethi yonke. Kunezilinganiso ezifana nalezi ze-"Exidzhad": 500 mg, 250 mg. Kunconywa ukuba uqale ukuthatha izidakamizwa ngomthamo we-20 mg / kg wesisindo somzimba wesiguli.

Njengoba kunesisindo esingenasiphelo esingasetshenzisiwe ngensimbi, umthamo wokuqala wezidakamizwa ungaphansi - 10 mg / kg wesisindo somzimba womuntu.

"Imfundo ye-Exidzhad" yokusetshenziswa isincoma ukuthatha isisu esingenalutho, cishe isigamu sehora ngaphambi kwesidlo sakamuva. Ithebhulethi kufanele ifakwe engilazini ngamanzi noma ijusi (200 mg we-liquid) bese uhlanganisa yonke into kuze kube yilapho ifomu le-slurry.

Imiphumela emibi nemiyalo ekhethekile

"I-Exidzhad" ingabangela ukuphendula okungafuneki komzimba okulandelayo:

• Izinwele;
• Izinkinga ngokuzwa;
• Ukuthuthukiswa kokuqala kwe-cataract;
• Ubuhlungu ku-pharynx ne-larynx;
• Isifo sohudo, ukuqotshwa;
• Ukudabuka, ukuhlanza;
• Rash;
• Ukungasebenzi kahle kwe-renal;
• Ukushisa komzimba okwandisiwe;
• I-Edema.

Udokotela kanye ne-oncologist banelungelo lokubeka izidakamizwa futhi bakhethe umthamo wayo. Uma ukwelashwa nomuthi "Eksidzhad" kubalulekile ukuqapha imingcele ye-hematological.